Skip to main content
Fig. 4 | BMC Urology

Fig. 4

From: Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute

Fig. 4

The association between biologically effective dose (BED) and urinary symptom flare. The BED calculated from post-implant dosimetry is depicted by Tukey box plots. Horizontal lines within boxes indicate median levels. a, Comparison of BED between the IPSS non-flare group (n = 272) and flare group (n = 83) in the 355 total patients. b and c, Comparison of BED between the IPSS non-flare group (n = 190) and flare group (n = 57) in the 247 patients who did not undergo supplementary EBRT (b) and between the OABSS non-flare group (n = 193) and flare group (n = 54) (c). Significance was tested using the Mann-Whitney U-test

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us